Skip to content
Axcess News – Lifestyle
Author:
Levicept
Levicept Appoints Darlene Deptula-Hicks as CFO
July 7, 2026
Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026
June 3, 2026
TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2026
April 24, 2026
Levicept to Present Data from Phase II study of LEVI-04 at OARSI 2026 World Congress on Osteoarthritis
April 24, 2026
Levicept Announces The Lancet Publication of LEVI-04 Phase II Clinical Trial Results, Showing Significant Reduction in Pain and Symptoms of Osteoarthritis
March 30, 2026